These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9169879)
1. From the Food and Drug Administration. Nightingale SL JAMA; 1997 Jun; 277(21):1664. PubMed ID: 9169879 [No Abstract] [Full Text] [Related]
2. Hydrazine and isoniazid. Blue PW Ann Intern Med; 2001 Nov; 135(10):927. PubMed ID: 11712886 [No Abstract] [Full Text] [Related]
3. Isoniazid-related fatal hepatitis. Salpeter SR West J Med; 1996 Nov; 165(5):323. PubMed ID: 8993215 [No Abstract] [Full Text] [Related]
4. [Hepatotoxicity caused by isoniazid or by paracetamol]. Andrade RJ; Lucena MI; Melgarejo F; García-Escaño MD Gastroenterol Hepatol; 1998; 21(6):314-5. PubMed ID: 9711017 [No Abstract] [Full Text] [Related]
5. [Antitubercular drug-induced liver injuries]. Guo Y; Cui D Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960 [No Abstract] [Full Text] [Related]
6. [Severe hepatitis induced by chemotherapy with antitubercular agents in childhood. 2 cases]. Chapoy P; Ferracci JP; Mattei JF; Granjon B; Louchet E Pediatrie; 1978; 3(7):637-45. PubMed ID: 740454 [No Abstract] [Full Text] [Related]
9. [Liver damage from tuberculosis treatment]. Keiner F Med Klin; 1981 Jun; 76(13):376-7. PubMed ID: 7254121 [No Abstract] [Full Text] [Related]
10. [Adverse effects of antitubercular agents]. Peng DH; Wang ZX Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Dec; 8(6):367-71. PubMed ID: 2942371 [No Abstract] [Full Text] [Related]
11. From the Food and Drug Administration. Nightingale SL JAMA; 1997 Dec; 278(21):1728. PubMed ID: 9388135 [No Abstract] [Full Text] [Related]
12. Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity. Lobato MN; Jereb JA; Starke JR Pediatrics; 2008 Jun; 121(6):e1732-3. PubMed ID: 18474531 [TBL] [Abstract][Full Text] [Related]
13. Isoniazid-induced acute hepatitis and acute pancreatitis in a patient during chemoprophylaxis. Jin CF; Sable R J Clin Gastroenterol; 2002 Jul; 35(1):100-1. PubMed ID: 12080238 [No Abstract] [Full Text] [Related]
14. [Clinically apparent liver damage during brief tuberculosis therapy]. Estay S; Armas Merino R; Vega C; Soto JR Rev Med Chil; 1981 Oct; 109(10):941-4. PubMed ID: 7344017 [No Abstract] [Full Text] [Related]
15. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)]. Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070 [TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions in TB therapy: risks and recommendations. Yoshikawa TT; Nagami PH Geriatrics; 1982 Jul; 37(7):61-8. PubMed ID: 7084671 [No Abstract] [Full Text] [Related]
19. [Clinical and pathological analysis of liver injury resulting from rifampin and isoniazid]. Xing T; Chen J; Zhang G Zhonghua Jie He He Hu Xi Za Zhi; 1997 Feb; 20(1):33-5. PubMed ID: 10072800 [TBL] [Abstract][Full Text] [Related]